{
  "docId": "019de075-f745-744d-a2c3-62fcecd316e9",
  "docSlug": "352ee416e6a97a9b39e1309fafdab0f3",
  "documentTitle": "Genelux | Investor Presentation Deck | 38 slides",
  "authorId": "genelux",
  "authorName": "Genelux",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 26,
  "pageCount": 38,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "go_to_market",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a hub-and-spoke style layout to show the four pillars supporting the central launch strategy.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/26",
  "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9",
  "deckJsonHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9.json",
  "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.07,
        "w": 0.5,
        "x": 0.25,
        "y": 0.135
      },
      "kind": "callout",
      "text": "Self Launch Olvi-Vec for Ovarian Cancer in the US",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "76977340-9f80-4bc1-b3e7-122008296b2a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.2,
        "x": 0.07,
        "y": 0.35
      },
      "kind": "list",
      "text": "Partnerships: Leverage partnership with GOG Foundation. Preeminent US-based cooperative group in Gynecologic Oncology. Composed of leading KOLs in the field. Partners in the OnPrime/GOG-3076 Phase 3 registration trial.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "493fcb20-83c6-4952-b003-3ea59460ab1b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.2,
        "x": 0.3,
        "y": 0.35
      },
      "kind": "list",
      "text": "Self-Manufacturing: Large-Scale cGMP Manufacturing. Control of Production Schedule. Attractive COGs. Ability to scale up modular process.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "76c85ec1-787e-4b21-abc8-bebef8c70214",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.2,
        "x": 0.76,
        "y": 0.35
      },
      "kind": "list",
      "text": "Reimbursement: Compelling Value Proposition for Payors. Significant unmet medical need. No SOC. Combination with generic/biosimilars.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "81ae72ad-681b-44b9-9303-32b203c90034",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.2,
        "x": 0.53,
        "y": 0.35
      },
      "kind": "list",
      "text": "Patients: Population without Standard of Care. PRROC patients lack effective SoC therapies. Limited number of Gyn-Oncs enabling specialty sales team. Label expansion starting with IV administration in 2L ovarian (Ph2 planned).",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e4978203-1d79-4d52-b556-1b49943c71e2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.3,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "Commercial Strategy",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4b857d5d-60e0-4023-8968-fe23998d96d2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "go-to-market-strategy",
      "slug": null,
      "matchId": "3af8f0f4-105f-4557-a09c-ee350827bdac",
      "evidence": "The slide outlines the core pillars of a commercial launch strategy.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 38,
      "from": 10,
      "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 26,
      "from": 24,
      "name": "Jobs To Be Done",
      "slug": "53-jobs-to-be-done",
      "bestFor": "Product innovation, market entry, competitive positioning",
      "matchId": "392920d4-0517-46aa-a9c2-4fb0dd0c15fd",
      "evidence": "The deck discusses the market opportunity and commercial potential of Olvi-Vec, highlighting its potential to address unmet needs.",
      "position": 1,
      "objective": "How can Olvi-Vec address the needs of patients and healthcare systems?",
      "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
      "confidence": 0.6,
      "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}